bismuth has been researched along with Human T-lymphotropic Virus 1 Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Waldmann, TA | 1 |
1 review(s) available for bismuth and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Topics: ADP Ribose Transferases; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Bacterial Toxins; Bismuth; Exotoxins; Gene Expression Regulation, Neoplastic; HTLV-I Infections; Humans; Immunologic Deficiency Syndromes; Immunotoxins; Leukemia-Lymphoma, Adult T-Cell; Mice; Molecular Sequence Data; Neoplasm Proteins; Protein Engineering; Pseudomonas aeruginosa Exotoxin A; Radioisotopes; Receptors, Interleukin-2; Virulence Factors; Yttrium Radioisotopes | 1994 |